The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Histone Deacetylase (HDAC) Inhibitors-Global Market Insights and Sales Trends 2025

Histone Deacetylase (HDAC) Inhibitors-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1806842

No of Pages : 106

Ask Your Query
Synopsis
The global Histone Deacetylase (HDAC) Inhibitors market size is expected to reach US$ 1223.2 million by 2029, growing at a CAGR of 8.8% from 2023 to 2029. The market is mainly driven by the significant applications of Histone Deacetylase (HDAC) Inhibitors in various end use industries. The expanding demands from the Treatment of Malignant Tumors, Chronic Disease Treatment and Others,, are propelling Histone Deacetylase (HDAC) Inhibitors market. Fatty Acid, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hydroxamate segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Histone Deacetylase (HDAC) Inhibitors market, driven by demand from China, the second largest economy with some signs of stabilising, the Histone Deacetylase (HDAC) Inhibitors market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Histone Deacetylase (HDAC) Inhibitors, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Histone Deacetylase (HDAC) Inhibitors market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Histone Deacetylase (HDAC) Inhibitors market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Histone Deacetylase (HDAC) Inhibitors sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Histone Deacetylase (HDAC) Inhibitors covered in this report include 4SC, Acetylon Pharmaceuticals, Celleron Therapeutics, Chipscreen Biosciences, Chroma Therapeutics, CrystalGenomics, Curis, MEI Pharma and Mirati Therapeutics, etc.
The global Histone Deacetylase (HDAC) Inhibitors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
4SC
Acetylon Pharmaceuticals
Celleron Therapeutics
Chipscreen Biosciences
Chroma Therapeutics
CrystalGenomics
Curis
MEI Pharma
Mirati Therapeutics
Novartis
Onxeo
Repligen
TetraLogic
Global Histone Deacetylase (HDAC) Inhibitors market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Histone Deacetylase (HDAC) Inhibitors market, Segment by Type:
Fatty Acid
Hydroxamate
Cyclic Peptide
Benzamide
Global Histone Deacetylase (HDAC) Inhibitors market, by Application
Treatment of Malignant Tumors
Chronic Disease Treatment
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Histone Deacetylase (HDAC) Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Histone Deacetylase (HDAC) Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Histone Deacetylase (HDAC) Inhibitors Market Overview
1.1 Histone Deacetylase (HDAC) Inhibitors Product Overview
1.2 Histone Deacetylase (HDAC) Inhibitors Market Segment by Type
1.2.1 Fatty Acid
1.2.2 Hydroxamate
1.2.3 Cyclic Peptide
1.2.4 Benzamide
1.3 Global Histone Deacetylase (HDAC) Inhibitors Market Size by Type
1.3.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size Overview by Type (2018-2029)
1.3.2 Global Histone Deacetylase (HDAC) Inhibitors Historic Market Size Review by Type (2018-2023)
1.3.3 Global Histone Deacetylase (HDAC) Inhibitors Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Type (2018-2023)
1.4.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Type (2018-2023)
2 Global Histone Deacetylase (HDAC) Inhibitors Market Competition by Company
2.1 Global Top Players by Histone Deacetylase (HDAC) Inhibitors Sales (2018-2023)
2.2 Global Top Players by Histone Deacetylase (HDAC) Inhibitors Revenue (2018-2023)
2.3 Global Top Players by Histone Deacetylase (HDAC) Inhibitors Price (2018-2023)
2.4 Global Top Manufacturers Histone Deacetylase (HDAC) Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 Histone Deacetylase (HDAC) Inhibitors Market Competitive Situation and Trends
2.5.1 Histone Deacetylase (HDAC) Inhibitors Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Histone Deacetylase (HDAC) Inhibitors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Histone Deacetylase (HDAC) Inhibitors as of 2022)
2.7 Date of Key Manufacturers Enter into Histone Deacetylase (HDAC) Inhibitors Market
2.8 Key Manufacturers Histone Deacetylase (HDAC) Inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Histone Deacetylase (HDAC) Inhibitors Status and Outlook by Region
3.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Histone Deacetylase (HDAC) Inhibitors Historic Market Size by Region
3.2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Region (2018-2023)
3.2.2 Global Histone Deacetylase (HDAC) Inhibitors Sales in Value by Region (2018-2023)
3.2.3 Global Histone Deacetylase (HDAC) Inhibitors Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Histone Deacetylase (HDAC) Inhibitors Forecasted Market Size by Region
3.3.1 Global Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Region (2024-2029)
3.3.2 Global Histone Deacetylase (HDAC) Inhibitors Sales in Value by Region (2024-2029)
3.3.3 Global Histone Deacetylase (HDAC) Inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Histone Deacetylase (HDAC) Inhibitors by Application
4.1 Histone Deacetylase (HDAC) Inhibitors Market Segment by Application
4.1.1 Treatment of Malignant Tumors
4.1.2 Chronic Disease Treatment
4.1.3 Others
4.2 Global Histone Deacetylase (HDAC) Inhibitors Market Size by Application
4.2.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size Overview by Application (2018-2029)
4.2.2 Global Histone Deacetylase (HDAC) Inhibitors Historic Market Size Review by Application (2018-2023)
4.2.3 Global Histone Deacetylase (HDAC) Inhibitors Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Application (2018-2023)
4.3.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Breakdown by Application (2018-2023)
5 North America Histone Deacetylase (HDAC) Inhibitors by Country
5.1 North America Histone Deacetylase (HDAC) Inhibitors Historic Market Size by Country
5.1.1 North America Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Country (2018-2023)
5.1.3 North America Histone Deacetylase (HDAC) Inhibitors Sales in Value by Country (2018-2023)
5.2 North America Histone Deacetylase (HDAC) Inhibitors Forecasted Market Size by Country
5.2.1 North America Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Country (2024-2029)
5.2.2 North America Histone Deacetylase (HDAC) Inhibitors Sales in Value by Country (2024-2029)
6 Europe Histone Deacetylase (HDAC) Inhibitors by Country
6.1 Europe Histone Deacetylase (HDAC) Inhibitors Historic Market Size by Country
6.1.1 Europe Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Country (2018-2023)
6.1.3 Europe Histone Deacetylase (HDAC) Inhibitors Sales in Value by Country (2018-2023)
6.2 Europe Histone Deacetylase (HDAC) Inhibitors Forecasted Market Size by Country
6.2.1 Europe Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Country (2024-2029)
6.2.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales in Value by Country (2024-2029)
7 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors by Region
7.1 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Historic Market Size by Region
7.1.1 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Forecasted Market Size by Region
7.2.1 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Histone Deacetylase (HDAC) Inhibitors Sales in Value by Region (2024-2029)
8 Latin America Histone Deacetylase (HDAC) Inhibitors by Country
8.1 Latin America Histone Deacetylase (HDAC) Inhibitors Historic Market Size by Country
8.1.1 Latin America Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Country (2018-2023)
8.1.3 Latin America Histone Deacetylase (HDAC) Inhibitors Sales in Value by Country (2018-2023)
8.2 Latin America Histone Deacetylase (HDAC) Inhibitors Forecasted Market Size by Country
8.2.1 Latin America Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Country (2024-2029)
8.2.2 Latin America Histone Deacetylase (HDAC) Inhibitors Sales in Value by Country (2024-2029)
9 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors by Country
9.1 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Historic Market Size by Country
9.1.1 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Forecasted Market Size by Country
9.2.1 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 4SC
10.1.1 4SC Company Information
10.1.2 4SC Introduction and Business Overview
10.1.3 4SC Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.1.4 4SC Histone Deacetylase (HDAC) Inhibitors Products Offered
10.1.5 4SC Recent Development
10.2 Acetylon Pharmaceuticals
10.2.1 Acetylon Pharmaceuticals Company Information
10.2.2 Acetylon Pharmaceuticals Introduction and Business Overview
10.2.3 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Products Offered
10.2.5 Acetylon Pharmaceuticals Recent Development
10.3 Celleron Therapeutics
10.3.1 Celleron Therapeutics Company Information
10.3.2 Celleron Therapeutics Introduction and Business Overview
10.3.3 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Products Offered
10.3.5 Celleron Therapeutics Recent Development
10.4 Chipscreen Biosciences
10.4.1 Chipscreen Biosciences Company Information
10.4.2 Chipscreen Biosciences Introduction and Business Overview
10.4.3 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Products Offered
10.4.5 Chipscreen Biosciences Recent Development
10.5 Chroma Therapeutics
10.5.1 Chroma Therapeutics Company Information
10.5.2 Chroma Therapeutics Introduction and Business Overview
10.5.3 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Products Offered
10.5.5 Chroma Therapeutics Recent Development
10.6 CrystalGenomics
10.6.1 CrystalGenomics Company Information
10.6.2 CrystalGenomics Introduction and Business Overview
10.6.3 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.6.4 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Products Offered
10.6.5 CrystalGenomics Recent Development
10.7 Curis
10.7.1 Curis Company Information
10.7.2 Curis Introduction and Business Overview
10.7.3 Curis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Curis Histone Deacetylase (HDAC) Inhibitors Products Offered
10.7.5 Curis Recent Development
10.8 MEI Pharma
10.8.1 MEI Pharma Company Information
10.8.2 MEI Pharma Introduction and Business Overview
10.8.3 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.8.4 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Products Offered
10.8.5 MEI Pharma Recent Development
10.9 Mirati Therapeutics
10.9.1 Mirati Therapeutics Company Information
10.9.2 Mirati Therapeutics Introduction and Business Overview
10.9.3 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Products Offered
10.9.5 Mirati Therapeutics Recent Development
10.10 Novartis
10.10.1 Novartis Company Information
10.10.2 Novartis Introduction and Business Overview
10.10.3 Novartis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Novartis Histone Deacetylase (HDAC) Inhibitors Products Offered
10.10.5 Novartis Recent Development
10.11 Onxeo
10.11.1 Onxeo Company Information
10.11.2 Onxeo Introduction and Business Overview
10.11.3 Onxeo Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Onxeo Histone Deacetylase (HDAC) Inhibitors Products Offered
10.11.5 Onxeo Recent Development
10.12 Repligen
10.12.1 Repligen Company Information
10.12.2 Repligen Introduction and Business Overview
10.12.3 Repligen Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Repligen Histone Deacetylase (HDAC) Inhibitors Products Offered
10.12.5 Repligen Recent Development
10.13 TetraLogic
10.13.1 TetraLogic Company Information
10.13.2 TetraLogic Introduction and Business Overview
10.13.3 TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.13.4 TetraLogic Histone Deacetylase (HDAC) Inhibitors Products Offered
10.13.5 TetraLogic Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Histone Deacetylase (HDAC) Inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Histone Deacetylase (HDAC) Inhibitors Industrial Chain Analysis
11.4 Histone Deacetylase (HDAC) Inhibitors Market Dynamics
11.4.1 Histone Deacetylase (HDAC) Inhibitors Industry Trends
11.4.2 Histone Deacetylase (HDAC) Inhibitors Market Drivers
11.4.3 Histone Deacetylase (HDAC) Inhibitors Market Challenges
11.4.4 Histone Deacetylase (HDAC) Inhibitors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Histone Deacetylase (HDAC) Inhibitors Distributors
12.3 Histone Deacetylase (HDAC) Inhibitors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock